1.39
0.02 (1.46%)
| Penutupan Terdahulu | 1.37 |
| Buka | 1.37 |
| Jumlah Dagangan | 980,518 |
| Purata Dagangan (3B) | 1,646,512 |
| Modal Pasaran | 95,195,424 |
| Harga / Jualan (P/S) | 0.600 |
| Harga / Buku (P/B) | 3.35 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| Margin Keuntungan | -54.23% |
| Margin Operasi (TTM) | -34.45% |
| EPS Cair (TTM) | -1.32 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 83.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 208.79% |
| Nisbah Semasa (MRQ) | 2.44 |
| Aliran Tunai Operasi (OCF TTM) | -35.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.69 M |
| Pulangan Atas Aset (ROA TTM) | -19.38% |
| Pulangan Atas Ekuiti (ROE TTM) | -144.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Neuronetics, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -1.00 |
|
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.17% |
| % Dimiliki oleh Institusi | 62.81% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Fourworld Capital Management Llc | 30 Sep 2025 | 568,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 20 Nov 2025 | Pengumuman | Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference |
| 12 Nov 2025 | Pengumuman | TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression |
| 04 Nov 2025 | Pengumuman | Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan |
| 31 Oct 2025 | Pengumuman | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 30 Oct 2025 | Pengumuman | Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence |
| 21 Oct 2025 | Pengumuman | Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call |
| 17 Sep 2025 | Pengumuman | New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD) |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |